BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17395382)

  • 1. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T; Sutak M; Jhamandas K
    Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
    Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
    Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons.
    Powell KJ; Quirion R; Jhamandas K
    Eur J Neurosci; 2003 Sep; 18(6):1572-83. PubMed ID: 14511336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms.
    Wang D; Chen P; Li Q; Quirion R; Hong Y
    Behav Brain Res; 2011 Aug; 221(1):83-90. PubMed ID: 21382419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons.
    Khasabova IA; Harding-Rose C; Simone DA; Seybold VS
    J Neurosci; 2004 Feb; 24(7):1744-53. PubMed ID: 14973253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of pronociceptive mediators and downregulation of opioid peptide by adrenomedullin following chronic exposure to morphine in rats.
    Wang D; Li J; Chen P; Hong Y
    Neuroscience; 2014 Nov; 280():31-9. PubMed ID: 25218960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats.
    Hong Y; Wang D; Chabot JG; Ma W; Chen P; Quirion R
    J Neurosci; 2010 Sep; 30(37):12508-16. PubMed ID: 20844145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study.
    Ma W; Zheng WH; Powell K; Jhamandas K; Quirion R
    Eur J Neurosci; 2001 Oct; 14(7):1091-104. PubMed ID: 11683901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.
    Grenier P; Wiercigroch D; Olmstead MC; Cahill CM
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):241-254. PubMed ID: 29481424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure.
    Lim G; Wang S; Mao J
    Brain Res; 2005 Oct; 1059(1):20-7. PubMed ID: 16150424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
    Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
    Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
    da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
    Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of spinal neuropeptides and prostaglandins in opioid physical dependence.
    Trang T; Sutak M; Quirion R; Jhamandas K
    Br J Pharmacol; 2002 May; 136(1):37-48. PubMed ID: 11976266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates.
    Belanger S; Ma W; Chabot JG; Quirion R
    Neuroscience; 2002; 115(2):441-53. PubMed ID: 12421610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
    McNaull B; Trang T; Sutak M; Jhamandas K
    Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.